Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lymphoma × Clozapine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Lymphoma 1 Leukemia 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1 Hemangioma, Capillary 1

Interventions

Gene Expression Profiling 10 Polymerase Chain Reaction 8 Amplified Fragment Length Polymorphism Analysis 8 Surveys and Questionnaires 7 Immunohistochemistry 7 Flow Cytometry 7 Microarray Analysis 6 Interviews as Topic 4 Rituximab 3 Psychiatric Rehabilitation 3 Immunologic Techniques 3 Gene Rearrangement 3 Data Collection 3 Cytogenetic Analysis 3 Biopsy 3 plerixafor 2 Therapeutics 2 Positron-Emission Tomography 2 Phlebotomy 2 Pharmacogenomic Testing 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Spectroscopy 2 Leukapheresis 2 Lenalidomide 2 In Situ Hybridization, Fluorescence 2 Hematologic Tests 2 Focus Groups 2 Drug Therapy 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡